日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Construction of lactylation (LA) risk signature in prostate cancer based on 4D fast DIA L-lactated quantitative genomics.

基于 4D 快速 DIA L-乳酸定量基因组学构建前列腺癌乳酸化 (LA) 风险特征

Zou Fan, Jin Yongchen, Zhang Ziteng, Zhang Yishan, Wang Mingdong, Zhu Fangge, Qiu Jinming, Ye Haoyuan, Fu Yi, Ping Hao

Adverse events associated with Lutetium-177-PSMA-617 (Pluvicto(®)) in advanced prostate cancer: a disproportionality analysis based on the fda's adverse event reporting system (FAERS)

晚期前列腺癌患者使用镥-177-PSMA-617 (Pluvicto®) 治疗的不良事件:基于FDA不良事件报告系统(FAERS)的不成比例分析

Jin, Yongchen; Zhang, Yishan; Wang, Mingshuai; Bai, Xiaoxuan; Ping, Hao; Xing, Nianzeng